Introduction

This page provides a comprehensive analysis of the known insider trading history of John F Ginascol. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders
Companies with Reported Insider Positions

The SEC filings indicate John F Ginascol has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ABT / Abbott Laboratories EXECUTIVE VICE PRESIDENT 118,380
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by John F Ginascol. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Trading History

This table shows the complete list of insider trades made by John F Ginascol as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change		 Share
Price		 Tran
Value		 Remaining
Value
2023-03-02 2023-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -943 118,380 -0.79 100.70 -94,960 11,920,866
2023-03-02 2023-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -6,859 119,323 -5.44 99.77 -684,322 11,904,856
2023-02-22 2023-02-17 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 14,270 126,182 12.75
2022-12-15 2022-12-13 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -11,000 111,912 -8.95 112.32 -1,235,520 12,569,956
2022-06-07 2022-06-03 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -1,768 122,912 -1.42 117.51 -207,758 14,443,389
2022-03-02 2022-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -5,876 125,045 -4.49 122.41 -719,281 15,306,758
2022-03-02 2021-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -365 124,680 -0.29 118.16 -43,128 14,732,214
2022-02-23 2022-02-18 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 80,380 80,380
2022-02-23 2022-02-18 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 17,247 130,921 15.17
2021-10-27 2021-10-27 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -45,709 0 -100.00
2021-10-27 2021-10-27 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -29,588 113,674 -20.65 128.13 -3,791,110 14,565,050
2021-10-27 2021-10-27 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 45,709 143,262 46.86 47.00 2,148,323 6,733,314
2021-06-07 2021-06-03 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -1,768 97,553 -1.78 106.90 -188,999 10,428,416
2021-03-02 2021-03-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -352 99,321 -0.35 120.61 -42,455 11,979,106
2021-03-02 2021-02-26 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -4,736 99,673 -4.54 121.58 -575,803 12,118,243
2021-02-23 2021-02-19 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 78,966 78,966
2021-02-23 2021-02-19 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 15,406 104,409 17.31
2020-09-03 2020-09-01 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -39,953 0 -100.00
2020-09-03 2020-09-01 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -20,133 0 -100.00
2020-09-03 2020-09-01 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -12,012 45,709 -20.81
2020-09-03 2020-09-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -47,772 89,003 -34.93 109.47 -5,229,601 9,743,158
2020-09-03 2020-09-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 39,953 136,775 41.26 44.40 1,773,913 6,072,810
2020-09-03 2020-09-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 20,133 96,822 26.25 38.40 773,107 3,717,965
2020-09-03 2020-09-01 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 12,012 76,689 18.57 47.00 564,564 3,604,383
2020-06-05 2020-06-03 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -1,768 64,677 -2.66 92.62 -163,752 5,990,384
2020-04-23 2020-04-21 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		M - Exercise -63,200 20,133 -75.84
2020-04-23 2020-04-21 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -39,234 66,445 -37.13 96.26 -3,776,630 6,395,936
2020-04-23 2020-04-21 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -23,966 105,679 -18.49 95.57 -2,290,421 10,099,700
2020-04-23 2020-04-21 4 ABT ABBOTT LABORATORIES
Common shares without par value 		M - Exercise 63,200 129,645 95.12 38.40 2,426,880 4,978,368
2020-03-03 2020-03-02 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -5,600 66,445 -7.77 77.58 -434,448 5,154,803
2020-03-03 2020-03-02 4 ABT ABBOTT LABORATORIES
Common shares without par value 		S - Sale -1,006 72,045 -1.38 77.89 -78,357 5,611,585
2020-03-03 2020-02-28 4 ABT ABBOTT LABORATORIES
Common shares without par value 		F - Taxes -2,246 73,051 -2.98 79.19 -177,861 5,784,909
2020-02-25 2020-02-21 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 114,940 114,940
2020-02-25 2020-02-21 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 18,855 75,297 33.41
2020-02-25 3/A ABT ABBOTT LABORATORIES
Common shares without par value 		44,475
2019-06-05 2019-06-03 4 ABT ABBOTT LABORATORIES
Option (right to buy) 		A - Award 62,725 62,725
2019-06-05 2019-06-03 4 ABT ABBOTT LABORATORIES
Common shares without par value 		A - Award 11,967 60,584 24.61
2019-06-05 3 ABT ABBOTT LABORATORIES
Common shares without par value 		97,234
2019-06-05 3 ABT ABBOTT LABORATORIES
Common shares without par value 		97,234
2019-06-05 3 ABT ABBOTT LABORATORIES
Common shares without par value 		97,234
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)